⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Powered Research at ARVO 2026
prnewswire.com
REGN
Over 60 Million Showed They Are #MoreThanMyeloma During 2026 Myeloma Action Month
globenewswire.com
AMGN
BMY
GSK
JNJ
REGN
SNY
PFE
Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis
globenewswire.com
KNSA
REGN
Form 8-K
sec.gov
REGN
SAS Innovate 2026 to feature new health care and life sciences AI capabilities and real-world use cases
prnewswire.com
JNJ
AZN
GILD
REGN
SNY
IQV
OGN
PFE
ABBV
ELV
CI
TriNetX arbeitet mit Regeneron zusammen, um Zugang zu anonymisierten elektronischen Patientenakten von 300 Millionen Patienten zu erhalten und damit die Forschung und Produktentwicklung in den Bereichen Biowissenschaften und digitale Gesundheitslösungen
prnewswire.com
REGN
Centri Announces Panel Topics and Featured Programming for Second Annual Capital Conference at Nasdaq on April 14
accessnewswire.com
NDAQ
DFIN
PTGX
STRL
TNDM
AXSM
CSTL
CYTK
GILD
INSM
KODK
NBIX
OCGN
REGN
SRPT
VRTX
XBIT
AMZN
GOOGL
MSFT
NVDA
IBM
ORGN
BWEN
CCJ
EXC
NEE
SO
UTL
XOM
BALY
OXY
PBF
CHRD
AX
BAC
MAXN
PHIO
KZR
SMX
DUOT
COIN
EHTH
TriNetX colabora con Regeneron para acceder a registros electrónicos de salud anonimizados USA - español USA - English India - English USA - Français Japan - Japanese
prnewswire.com
REGN
TriNetX collabore avec Regeneron pour accéder aux dossiers médicaux électroniques dépersonnalisés de 300 millions de patients afin de stimuler la recherche et le développement de produits dans le domaine des sciences de la vie et des solutions de santé
prnewswire.com
REGN
TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions USA - English India - English
prnewswire.com
REGN